Management of small-cell lung cancer

被引：32
作者：
Thatcher, N [1 ]
Faivre-Finn, C [1 ]
Lorigan, P [1 ]
机构：
[1] Christie Hosp, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
10.1093/annonc/mdi700
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：235 / 239
页数：5
相关论文
共 50 条
[31]   PREDICTING SEPTIC COMPLICATIONS OF CHEMOTHERAPY - AN ANALYSIS OF 382 PATIENTS TREATED FOR SMALL-CELL LUNG-CANCER WITHOUT DOSE REDUCTION AFTER MAJOR SEPSIS [J].
RADFORD, JA ;
RYDER, WDJ ;
DODWELL, D ;
ANDERSON, H ;
THATCHER, N .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) :81-86
[32]   Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer [J].
Reck, M ;
von Pawel, J ;
Macha, HN ;
Kaukel, E ;
Deppermann, KM ;
Bonnet, R ;
Ulm, K ;
Hessler, S ;
Gatzemeier, U .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) :1118-1127
[33]   The role of new targeted therapies in small-cell lung cancer [J].
Rossi, A ;
Maione, P ;
Colantuoni, G ;
Guerriero, C ;
Gridelli, C .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 51 (01) :45-53
[34]   RANDOMIZED STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS ETOPOSIDE AND CISPLATIN VERSUS ALTERNATION OF THESE 2 REGIMENS IN EXTENSIVE SMALL-CELL LUNG-CANCER - A PHASE-III TRIAL OF THE SOUTHEASTERN CANCER STUDY-GROUP [J].
ROTH, BJ ;
JOHNSON, DH ;
EINHORN, LH ;
SCHACTER, LP ;
CHERNG, NC ;
COHEN, HJ ;
CRAWFORD, J ;
RANDOLPH, JA ;
GOODLOW, JL ;
BROUN, GO ;
OMURA, GA ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :282-291
[35]   Chemotherapy for small cell lung cancer [J].
Sandler, AB .
SEMINARS IN ONCOLOGY, 2003, 30 (01) :9-25
[36]   Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer [J].
Schild, SE ;
Bonner, JA ;
Shanahan, TG ;
Brooks, BJ ;
Marks, RS ;
Geyer, SM ;
Hillman, SL ;
Farr, GH ;
Tazelaar, HD ;
Krook, JE ;
Geoffroy, FJ ;
Salim, M ;
Arusell, RM ;
Mailliard, JA ;
Schaefer, PL ;
Jett, JR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04) :943-951
[37]   Five-day oral etoposide treatment for advanced small-cell lung cancer: Randomized comparison with intravenous chemotherapy [J].
Souhami, RL ;
Spiro, SG ;
Rudd, RM ;
deElvira, MCR ;
James, LE ;
Gower, NH ;
Lamont, A ;
Harper, PG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (08) :577-580
[38]   Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up [J].
Sundstrom, S ;
Bremnes, RM ;
Kaasa, S ;
Aasebo, U ;
Hatlevoll, R ;
Dahle, R ;
Boye, N ;
Wang, M ;
Vigander, T ;
Vilsvik, J ;
Skovlund, E ;
Hannisdal, E ;
Aamdal, S .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) :4665-4672
[39]   Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104 [J].
Takada, M ;
Fukuoka, M ;
Kawahara, M ;
Sugiura, T ;
Yokoyama, A ;
Yokota, S ;
Niskiwaki, Y ;
Watanabe, K ;
Noda, K ;
Tamura, T ;
Fukuda, H ;
Saijo, N .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3054-3060
[40]  
Thatcher, 1995, Semin Radiat Oncol, V5, P19, DOI 10.1016/S1053-4296(05)80005-0
12345